pharmaphorum

NOVEMBER 5, 2021

In the latest episode of the podcast Dominic Tyer speaks with Pierre Bourdage, who’s global head of biopharmaceuticals at Sandoz about the big issues in biosimilars. The post Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcast appeared first on.

98

98

pharmaphorum

SEPTEMBER 23, 2021

Joining the pharmaphorum podcast to discuss these changes is Impetus Digital’s co-founder and CEO Natalie Yeadon, in a special episode sponsored by the virtual engagement agency. Natalie also discusses how she came to found Impetus and the evolution of the pharma industry’s approach to virtual collaborations.

98

98

pharmaphorum

FEBRUARY 10, 2022

In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe). Many of the key technologies in pharma have arrived, Goldsack says; this year will be all about how we pay for them and how we integrate them into the systems we have now.

94

94

pharmaphorum

DECEMBER 17, 2021

This episode of the pharmaphorum podcast is the second in a limited series focused on patient engagement that’s being led by clinician, consultant and patient advocate, Mark Duman. The post Patient engagement processes: the pharmaphorum podcast appeared first on.

98

98

pharmaphorum

DECEMBER 22, 2022

Magnelli explains how the purpose of the investment is to continue with a focus on the evolution of biotechnology and R&D. The post Focusing on the evolution of biotechnology and R&D – the pharmaphorum podcast appeared first on.

FDA 98

FDA 98

pharmaphorum

AUGUST 25, 2022

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular. . pharmaphorum podcast ?in Tune in to learn more. . Podbean. .

Vaccines 52

Vaccines Immunization 52

pharmaphorum

OCTOBER 20, 2022

They also discuss Thomas’s background in pharma and how it informs his current work. You can listen to episode 63 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on iTunes , Spotify , acast , Stitcher , and Podbean.

97

97

pharmaphorum

DECEMBER 8, 2022

The conversation concludes on how tangible innovation and data speaks for itself. You can listen to episode 70 of the pharmaphorum podcast in the player below, download the episode to your computer or find it – and subscribe to the rest of the series in iTunes , Spotify , Stitcher, and Podbean.

Vaccines 98

Vaccines 98

pharmaphorum

JANUARY 14, 2022

In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo executive vice president and general manager of Worldwide Clinical Trials Early Phase Services, Keith Fern. The post The evolution of clinical trials: the pharmaphorum podcast appeared first on.

Communication 98

Communication 98

pharmaphorum

NOVEMBER 12, 2021

Episode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change and which of those he sees holding the most potential to improve patient outcomes. The post Merck on trends in oncology: the pharmaphorum podcast appeared first on.

52

52

pharmaphorum

OCTOBER 6, 2022

And understanding this environment is key to understanding cancers and how they evade the body’s immune system. Together they discuss what it means to talk about a cell being “clever”, and how drug developers are working to be even cleverer – and outsmart the many different kinds of cancers that afflict patients today.

Immunization 52

Immunization 52

pharmaphorum

JULY 28, 2022

On the latest instalment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Dr Benny Alouf, chief medical officer at Limbix to discuss his company’s digital therapeutic for teen depression. The post Building a digital therapeutic for paediatric behavioural health – the pharmaphorum podcast appeared first on.

52

52

pharmaphorum

NOVEMBER 10, 2022

In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock sits down with Russell Potterfield, CEO at Endevica Pharma. The post A new hope in cachexia and an outsider’s view on pharma: the pharmaphorum podcast appeared first on.

52

52

pharmaphorum

JULY 5, 2022

On the latest instalment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Tony Mack, CEO at Virpax Pharmaceuticals, in the virtual studio. . Mack discusses some of his own company’s in-progress offerings, but also discusses the opioid epidemic, and how the industry can learn from it moving forward. . Podbean. .

52

52

pharmaphorum

MARCH 24, 2022

In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Miruna Sasu, chief strategy officer of COTA and long-time pharma vet– before joining COTA last year, she headed up J&J’s Clinical Trial Feasibility and Advanced Analytics Team and led the Digital Health and Innovation Team at Bristol Myers Squibb.

52

52

pharmaphorum

APRIL 29, 2022

In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Dr Colin Banas, chief medical officer at DrFirst. Tune in to learn how at the intersection of patient empowerment and digital health, lies the potential to reduce the impact of high drug prices, if not to mitigate it entirely.

52

52

pharmaphorum

FEBRUARY 26, 2021

A former NHS doctor, he noted how stressful and draining some days can be when working at healthcare’s frontline – even in normal times, and that the current fight against the pandemic brings little respite to staff. The post Roche on COVID-19 healthcare and testing: the pharmaphorum podcast appeared first on.

80

80

pharmaphorum

OCTOBER 15, 2021

Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and communications. As part of that we looked at how she approaches the 19 markets she oversees and the challenges that can present.

Communication 52

Communication 52

pharmaphorum

SEPTEMBER 22, 2022

In today’s pharmaphorum podcast, Florian Baeres, Corporate Vice President for global medical affairs at Novo Nordisk, joins editor in chief Jonah Comstock to talk about the innovative once-weekly insulin currently in development and how it could change the game for people currently managing their type 2 diabetes with daily injections.

52

52

pharmaphorum

APRIL 30, 2021

Episode 35 of the pharmaphorum podcast hears from Michael Smyth about Galapagos UK and joining the company as medical director just as COVID-19 hit. The post Galapagos UK’s Michael Smyth on RNA-based tech: the pharmaphorum podcast appeared first on.

Compounding 52

Compounding Vaccines 52

pharmaphorum

NOVEMBER 17, 2021

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the speakers discuss qualitative real-world evidence and a unique dementia project from Singapore. They also discuss patient experience data, how it can be collected and how pharmaceutical regulatory authorities view it today.

Cerner 52

Cerner 52

pharmaphorum

NOVEMBER 17, 2021

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the speakers discuss qualitative real-world evidence and a unique dementia project from Singapore. They also discuss patient experience data, how it can be collected and how pharmaceutical regulatory authorities view it today.

Cerner 52

Cerner 52

pharmaphorum

NOVEMBER 28, 2022

Amidst all this, Adelphi Group’s CEO Stuart Cooper found a moment to sit with pharmaphorum web editor Nicole Raleigh and discuss just how exciting it was to bring to vibrant and discursive life the ethos of Anthropy – a united vision for British business, including pharma, and the future of this nation overall.

Patient Care 98

Patient Care 98

pharmaphorum

JANUARY 29, 2021

The theme for episode 28 of the pharmaphorum podcast is diversity and inclusion in pharma, ably addressed by AstraZeneca’s Rebekah Martin. Serving as senior vice president of reward and inclusion at AstraZeneca, Rebekah discussed how the pharmaceutical industry approaches the promotion of diversity.

52

52

The People's Pharmacy

MARCH 23, 2023

That is how public radio stays healthy. Hear How You Can Take Control of Your Health: Each week you can hear the latest expert opinions on cutting edge medical research and get real news you can use to take control of your own health. You can find The People’s Pharmacy podcast among the Apple offerings.

53

53

pharmaphorum

JUNE 6, 2022

In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock catches up with Pervaise Khan, Managing Director of Life Sciences, UK and Ireland, Accenture. Tune in for a consultant’s perspective on the pharma industry and how to do right by patients while still running a successful, profitable company.

40

40

pharmaphorum

SEPTEMBER 8, 2021

The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges that biotechnology companies face, with a particular focus on oncology. Alternatively, you can find – and subscribe – to the series, and other pharmaphorum podcasts in iTunes , Spotify , acast, Stitcher and Podbean.

52

52

pharmaphorum

JUNE 30, 2021

In the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder and CEO of RxE2. He explores how COVID-19 has disrupted healthcare delivery and why virtual and decentralised trials could help increase patient access.

52

52

pharmaphorum

DECEMBER 22, 2020

In episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU regional vice president at J&J Surgical Vision. Like pretty much every episode I’ve recorded since March this year the coronavirus features, and Erin tells me how she and her company have fared during the COVID-19 pandemic.

52

52

pharmaphorum

MAY 28, 2021

In this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about the trends that emerged in this year’s Q1 results season. He discussed how COVID vaccines have raised the profile of the pharma industry in the perception of the general public.

Vaccines 52

Vaccines 52

Omnicell

SEPTEMBER 5, 2022

This is why I’m excited to announce that Omnicell is jumping into the virtual conversation with the launch of our new podcast, The Future of Pharmacy. Subscribe to the show today on your favorite podcast platform, including Apple Podcasts, iHeartRadio, Spotify, CastBox, and Google Podcasts.

Omnicell 52

Omnicell Inventory Control 52

pharmaphorum

AUGUST 27, 2020

Alnylam’s Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company’s work in gene-silencing and how it could offer a route to target the current coronavirus pandemic. The post Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast appeared first on.

52

52

pharmaphorum

OCTOBER 13, 2022

In this episode of the pharmaphorum podcast series, Dr Paul Tunnah chats with Jeff Baxter, CEO of VBI Vaccines and Lee Taurman, executive vice president full service commercial at Syneos Health. They also discuss the changing world of commercial partnership in pharma, and how VBI and Syneos work together in an agile way.

Vaccines 52

Vaccines 52

pharmaphorum

DECEMBER 23, 2022

Johnston also shares how she revelled in the wide range of discussions held at Anthropy, while the notion of change was a hot topic. The post Exploring the importance we play in our own health maintenance – a pharmaphorum podcast extra appeared first on.

52

52

pharmaphorum

MARCH 23, 2021

This instalment of the podcast considers the meaning of digital innovation, both in pharma and outside the industry, and features digital transformation leader Edwin Erckens. The post The meaning of digital innovation: the pharmaphorum podcast appeared first on. About Exeevo.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

MARCH 12, 2021

In episode 31 of the pharmaphorum podcast, Deep Dive editor George Underwood speaks to RedHill biopharma’s chief business officer Guy Goldberg about the potential for new COVID-19 therapeutics to help fight the pandemic and treat patients in the years to come. The post New ways to treat COVID: the pharmaphorum podcast appeared first on.

Vaccines 52

Vaccines 52

pharmaphorum

JANUARY 5, 2023

During the interview, Rossi explains how the Economist Impact conference brings multi-stakeholders together – EU Parliamentary figures, patient advocacy groups, physicians – to look at the serial crises suffered the last few years and how they have affected cancer patients, and how partnerships can improve outcomes.

52

52